Ann Thorac Surg 1999;68:1397-1399
© 1999 The Society of Thoracic Surgeons
a Clinic for Cardiovascular Surgery, Geneva, Switzerland
b Department of Anesthesiology, Geneva, Switzerland
c Department of Cardiology, University Cantonal Hospital of Geneva, Geneva, Switzerland
Address reprint requests to Dr Kalangos, Clinic for Cardiovascular Surgery, University Cantonal Hospital of Geneva, 24, rue Micheli-du-Crest, 1211 Geneva 14, Switzerland
We report the use of transmyocardial laser revascularization in combination with partial left ventriculectomy for treatment of end-stage dilated ischemic cardiomyopathy. The disappearance of the reversible perfusion defects in the treated left ventricular territories and improvement of the systolic function led us to believe that the simultaneous use of these two techniques was complementary in our patient.
This article has been cited by other articles:
M. Ruel, R. A. Kelly, and F. W. Sellke
Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy
, January 1, 2003; 2(2003): 715 - 750.
|HOME||HELP||FEEDBACK||SUBSCRIPTIONS||ARCHIVE||SEARCH||TABLE OF CONTENTS|
|ANN THORAC SURG||ASIAN CARDIOVASC THORAC ANN||EUR J CARDIOTHORAC SURG|
|J THORAC CARDIOVASC SURG||ICVTS||ALL CTSNet JOURNALS|